Molecular Haematology and Cancer Biology Unit, Institute of Child Health, University College London, United Kingdom.
Adv Cancer Res. 2009;105:115-32. doi: 10.1016/S0065-230X(09)05007-6.
In no other field has the function of clusterin (CLU) been more controversial than in cancer genetics. After more than 20 years of research, there is still uncertainty with regard to the role of CLU in human cancers. Some investigators believe CLU to be an oncogene, others-an inhibitor of tumorigenesis. However, owing to the recent efforts of several laboratories, the role of CLU in important cellular processes like proliferation, apoptosis, differentiation, and transformation is beginning to emerge. The "enigmatic" CLU is becoming less so. In this chapter, we will review the work of research teams interested in understanding how CLU is regulated by oncogenic signaling. We will discuss how and under what circumstances oncogenes and epigenetic factors modify CLU expression, with important consequences for mammalian tumorigenesis.
在任何其他领域,CLU 的功能都没有像在癌症遗传学中那样引起更多的争议。经过 20 多年的研究,CLU 在人类癌症中的作用仍然不确定。一些研究人员认为 CLU 是致癌基因,而另一些人则认为它是肿瘤发生的抑制剂。然而,由于最近几个实验室的努力,CLU 在增殖、凋亡、分化和转化等重要细胞过程中的作用开始显现。这个“神秘”的 CLU 变得不再那么神秘。在本章中,我们将回顾对了解 CLU 如何受致癌信号调节感兴趣的研究团队的工作。我们将讨论致癌基因和表观遗传因素如何以及在什么情况下改变 CLU 的表达,这对哺乳动物的肿瘤发生有重要影响。